Outlook Therapeutics (OTLK) EBT Growth (3y) (2018 - 2026)
Outlook Therapeutics (OTLK) EBT Growth (3y) (2018 - 2026) Analysis & Trends
Peer Comparison
| # |
Company |
Market Cap |
Enterprise Value |
Gross Profit (Qtr) |
EBT Growth (3y) (Qtr) |
| 1 |
Alterity Therapeutics |
719,706.53 Bn |
719,706.50 Bn |
- |
- |
| 2 |
Belite Bio |
55,800.00 Bn |
55,800.00 Bn |
- |
84.25% |
| 3 |
Quantum Biopharma |
18,182.30 Bn |
18,182.29 Bn |
- |
32.96% |
| 4 |
Legend Biotech |
3,154.00 Bn |
3,153.71 Bn |
242.10 Mn |
28.95% |
| 5 |
Akari Therapeutics |
1,844.30 Bn |
1,844.29 Bn |
- |
-49.71% |
| 6 |
Evaxion A |
1,567.96 Bn |
1,567.94 Bn |
- |
20.92% |
| 7 |
Psyence Biomedical |
251.43 Bn |
251.42 Bn |
- |
- |
| 8 |
Vertex Pharmaceuticals |
112.56 Bn |
105.31 Bn |
2.59 Bn |
12.01% |
| 9 |
Abivax |
94.37 Bn |
94.37 Bn |
- |
- |
| 10 |
Outlook Therapeutics |
51.56 Mn |
43.81 Mn |
-21,888.00 |
12.52% |
| Date | Value |
|---|
| Mar 31, 2026 |
12.52% |
| Dec 31, 2025 |
4.92% |
| Sep 30, 2025 |
-1.16% |
| Jun 30, 2025 |
-4.74% |
| Mar 31, 2025 |
-33.00% |
| Dec 31, 2024 |
-18.00% |
| Sep 30, 2024 |
34.34% |
| Jun 30, 2024 |
78.01% |
| Mar 31, 2024 |
-105.84% |
| Dec 31, 2023 |
10.40% |
| Sep 30, 2023 |
-9.40% |
| Jun 30, 2023 |
-48.72% |
| Mar 31, 2023 |
-5.28% |
| Dec 31, 2022 |
-21.34% |
| Sep 30, 2022 |
-4.06% |
| Jun 30, 2022 |
-49.80% |
| Mar 31, 2022 |
-24.36% |
| Dec 31, 2021 |
-10.52% |
| Sep 30, 2021 |
-1.82% |
| Jun 30, 2021 |
-13.09% |
